Prot# CASM981CUS22: An Exploratory, Double-Blind, Randomized, Vehicle-Controlled, Paired Study to Evaluate the Efficacy&Safety of Concomitant Use of Pimecrolimus Cream 1% & Fluticasone Propionate Cream 0.05% in Ptnts w/Severe Lesions of Atopic Dermatitis

Project: Research project

Project Details

StatusFinished
Effective start/end date11/1/04 → 2/5/08

Funding

  • Novartis Pharmaceuticals Corporation (CASM981CUS22)